The Glipizide Tablets, cataloged under National Stock Number 6505-01-391-1079, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Rising Pharma Holdings, Inc. Dba Rising Pharmaceuticals. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-391-1079 |
| Primary Part Number | NDC64980-0280-01 |
| Item Name | Glipizide Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Rising Pharma Holdings, Inc. Dba Rising Pharmaceuticals |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 5.000 MILLIGRAMS GLIPIZIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC64980-0280-01 PRIMARY | Rising Pharma Holdings, Inc. Dba Rising Pharmaceuticals (USA) |
| NDC59651-0781-01 PRIMARY | Aurobindo Pharma Usa Inc Dba Aurobindo Pharma U S a Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00049-0174-02 | 5/9 Secondary reference U.S. Government activity |
| NDC00591-0844-01 | 3/9 Design control — primary reference Actavis Pharma, Inc. |
NSN 6505-01-391-1079 is a Glipizide Tablets, manufactured by Rising Pharma Holdings, Inc. Dba Rising Pharmaceuticals, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-391-1079 has 2 manufacturer part numbers on file: NDC64980-0280-01 (Rising Pharma Holdings, Inc. Dba Rising Pharmaceuticals), NDC59651-0781-01 (Aurobindo Pharma Usa Inc Dba Aurobindo Pharma U S a Inc).
Key specifications for NDC64980-0280-01: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: EXTENDED RELEASE TABLETS. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.